Phosphoproteomic analysis identifies focal adhesion kinase 2 (FAK2) as a potential therapeutic target for tamoxifen resistance in breast cancer
Xinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, Raja Sekhar Nirujogi, Min Sik Kim, Srikanth S. Manda, Vered Stearns, Edward Gabrielson, Saraswati Sukumar, Akhilesh Pandey
Dive into the research topics of 'Phosphoproteomic analysis identifies focal adhesion kinase 2 (FAK2) as a potential therapeutic target for tamoxifen resistance in breast cancer'. Together they form a unique fingerprint.